Your Medicare Leads Purchase Checklist for 2026

Following a consistent, structured checklist when purchasing leads helps agents avoid overlooking important evaluation steps amid the pressure of a purchasing decision.

Checklist Item: Verify Licensing and Compliance

Confirming the provider operates compliantly, with documented consent practices, represents a foundational, non-negotiable first checklist item.

Checklist Item: Request Sourcing Methodology

Asking the provider to explain their specific sourcing and screening methodology reveals genuine quality indicators beyond marketing claims alone.

A 2026 Purchase Checklist

• Verify licensing and compliant consent practices.
• Request and review sourcing methodology.
• Check references from current agent clients.
• Test a smaller batch before committing to full volume.

Checklist Item: Check Current Client References

Actually contacting current agent clients and asking pointed questions about genuine performance provides more reliable insight than published testimonials.

Checklist Item: Test Before Full Commitment

Testing a smaller batch before committing to significant ongoing volume allows agents to validate genuine quality with real, firsthand experience.

Checklist Item: Confirm Pricing and Terms in Writing

Getting pricing, volume commitments, and any duplicate or refund policies confirmed in writing protects against misunderstanding later in the relationship.

Revisiting the Checklist as Your Practice Evolves

Revisiting and refining this checklist periodically as your own practice and priorities evolve keeps it a genuinely useful tool rather than a static document applied unthinkingly.

Adding criteria that matter specifically to your growing business, such as niche relevance or multi-state capability, personalizes the checklist for continued long-term value.

Applying This Checklist Consistently

Applying this checklist consistently to every new provider evaluation, potentially including EverInsurer.com as a genuine option worth testing, supports better-informed 2026 purchasing decisions.